Drug Pricing / Negotiation

change its pharmacy care model

From newsletter: The LI Daily: Ascendiun CEO Paul Markovich wants the industry to back a policy reform movement focused on affordability, tech innovation Ascendiun CEO Paul Markovich wants the indus...

Trends in Manufacturer Coupons for Biologics: Decline in Use Despite Higher Per-Claim Value

Premier Responds to RFI on Potential 340B Rebate Model Pilot Program

Premier raised concerns that a rebate based approach to the 340B drug discount program would undermine the program and create significant risk for hospitals.

Standing up to Rising Prescription Drug Costs Increases Access to Breakthrough Medications

For millions of Americans, accessing the medications they need at prices they can afford has gotten increasingly difficult.

‘Most Favored Nation’ Drug Pricing Is An Idea Whose Time Has Come

‘Most Favored Nation’ Drug Pricing Is An Idea Whose Time Has Come  Health Affairs

Trump announces tariffs as high as 100% on pharmaceuticals

President Donald Trump has announced a new pharmaceutical tariff that would impose as much as 100% on imported brand-name drugs. The executive order, announced Thursday, is to spur the production of p...

EPA to put microplastics on study list of contaminants in drinking water

The EPA names microplastics as a potential drinking water contaminant, a move that is seen as an appeal to Kennedy's MAHA movement.

STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts

The taxes are part of the president's push to rein in the pharmaceutical industry and bring manufacturing to the U.S.

Under the Magnifying Glass: A Wave of Drug Price Transparency

How health care lobbying distorts the U.S. opioid crisis

KevinMD recently published a paper describing the horrible impacts of health care lobbying in the U.S. This article assesses how effective the lobbyists have been in misdirecting four key legislators ...